4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-017533
Chief Financial Officer gave up 10,177 shares (to pay taxes)
- Chief Financial Officer acquired 34,047 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ruffo Frank Chief Financial Officer | 2021-03-01 | Option exercise | +25,750 | 240,939 | D | ||
| Ruffo Frank Chief Financial Officer | 2021-03-01 | Shares withheld for taxes | −7,333 | $24.06 | $176,432 | 233,606 | D |
| Ruffo Frank Chief Financial Officer | 2021-03-02 | Option exercise | +8,297 | 241,903 | D | ||
| Ruffo Frank Chief Financial Officer | 2021-03-02 | Shares withheld for taxes | −2,844 | $23.25 | $66,123 | 239,059 | D |
| Derivatives | |||||||
| Ruffo Frank Chief Financial Officer | 2021-03-01 | Grant or award · Employee Stock Option (Right to Buy) | +116,000 | 116,000 | D | ||
| Ruffo Frank Chief Financial Officer | 2021-03-01 | Grant or award · Restricted stock units | +33,200 | 33,200 | D | ||
| Ruffo Frank Chief Financial Officer | 2021-03-01 | Option exercise · Restricted stock units | −25,750 | 51,500 | D | ||
| Ruffo Frank Chief Financial Officer | 2021-03-02 | Option exercise · Restricted stock units | −8,297 | 24,892 | D | ||
Loading xslF345X03/doc4.xml…